fluconazole

Generic: fluconazole

Labeler: slate run pharmaceuticals
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name fluconazole
Generic Name fluconazole
Labeler slate run pharmaceuticals
Dosage Form POWDER, FOR SUSPENSION
Routes
ORAL
Active Ingredients

fluconazole 40 mg/mL

Manufacturer
Slate Run Pharmaceuticals

Identifiers & Regulatory

Product NDC 70436-227
Product ID 70436-227_2c3342fa-abe7-d6b0-e063-6394a90ad1c0
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA215738
Listing Expiration 2026-12-31
Marketing Start 2024-01-01

Pharmacologic Class

Established (EPC)
azole antifungal [epc]
Mechanism of Action
cytochrome p450 2c19 inhibitors [moa] cytochrome p450 3a4 inhibitors [moa] cytochrome p450 2c9 inhibitors [moa]
Chemical Structure
azoles [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 70436227
Hyphenated Format 70436-227

Supplemental Identifiers

RxCUI
310353
UPC
0370436227488
UNII
8VZV102JFY
NUI
N0000175487 M0002083 N0000182140 N0000182141 N0000185504

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name fluconazole (source: ndc)
Generic Name fluconazole (source: ndc)
Application Number ANDA215738 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 40 mg/mL
source: ndc
Packaging
  • 1 BOTTLE in 1 CARTON (70436-227-48) / 35 mL in 1 BOTTLE
source: ndc

Packages (1)

Ingredients (1)

fluconazole (40 mg/mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "2c3342fa-abe7-d6b0-e063-6394a90ad1c0", "openfda": {"nui": ["N0000175487", "M0002083", "N0000182140", "N0000182141", "N0000185504"], "upc": ["0370436227488"], "unii": ["8VZV102JFY"], "rxcui": ["310353"], "spl_set_id": ["13804efd-7cb3-431f-a6a7-bd6d1da5889e"], "pharm_class_cs": ["Azoles [CS]"], "pharm_class_epc": ["Azole Antifungal [EPC]"], "pharm_class_moa": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]"], "manufacturer_name": ["Slate Run Pharmaceuticals"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (70436-227-48)  / 35 mL in 1 BOTTLE", "package_ndc": "70436-227-48", "marketing_start_date": "20240101"}], "brand_name": "Fluconazole", "product_id": "70436-227_2c3342fa-abe7-d6b0-e063-6394a90ad1c0", "dosage_form": "POWDER, FOR SUSPENSION", "pharm_class": ["Azole Antifungal [EPC]", "Azoles [CS]", "Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]"], "product_ndc": "70436-227", "generic_name": "Fluconazole", "labeler_name": "Slate Run Pharmaceuticals", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Fluconazole", "active_ingredients": [{"name": "FLUCONAZOLE", "strength": "40 mg/mL"}], "application_number": "ANDA215738", "marketing_category": "ANDA", "marketing_start_date": "20240101", "listing_expiration_date": "20261231"}